Free Trial

NewAmsterdam Pharma (NAMS) Institutional Ownership

NewAmsterdam Pharma logo
$37.75 -1.14 (-2.93%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$37.80 +0.05 (+0.15%)
As of 05:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)

Current
Institutional Ownership
Percentage
89.89%
Number of
Institutional Buyers
(last 12 months)
123
Total
Institutional Inflows
(last 12 months)
$599.94M
Number of
Institutional Sellers
(last 12 months)
54
Total
Institutional Outflows
(last 12 months)
$605.52M
Get NAMS Insider Trade Alerts

Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

NAMS Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.55,637$1.78M0.0%+35.6%0.048%
5/14/2026 Walleye Capital LLC58,434$1.87M0.0%-39.3%0.051%
5/13/2026Mizuho Markets Cayman LP52,227$1.67M0.1%+9.1%0.045%
5/13/2026Decheng Capital LLC325,057$10.41M1.6%-45.1%0.283%
5/13/2026First Trust Advisors LP267,105$8.55M0.0%-4.5%0.232%
5/8/2026 PNC Financial Services Group Inc.9,119$292K0.0%+147.7%0.008%
5/7/2026 AlphaCentric Advisors LLC14,656$469K0.5%+6.7%0.013%
5/7/2026 KBC Group NV1,171$37K0.0%N/A0.001%
5/7/2026 SEB Asset Management AB272,654$8.73M0.0%N/A0.237%
5/6/2026 Jennison Associates LLC2,750,403$88.04M0.1%-21.2%2.392%
5/5/2026 Bank of New York Mellon Corp378,800$12.13M0.0%-3.3%0.329%
4/29/2026 Swedbank AB100,900$3.23M0.0%+11.0%0.088%
4/25/2026 Keybank National Association OH12,480$399K0.0%-4.7%0.011%
4/24/2026 Peregrine Capital Management LLC178,493$5.71M0.2%N/A0.155%
4/22/2026 Pictet Asset Management Holding SA6,533$209K0.0%-99.1%0.006%
4/22/2026 Medicxi Ventures Management Jersey Ltd2,674,182$85.60M8.7%-6.8%2.326%
4/17/2026 AdvisorNet Financial Inc2,565$82K0.0%N/A0.002%
2/26/2026Seven Fleet Capital Management LP4,000$140K0.1%N/A0.004%
2/19/2026 Invesco Ltd.5,961$209K0.0%-94.3%0.005%
2/18/2026Empowered Funds LLC2,428$85K0.0%N/A0.002%
2/18/2026XTX Topco Ltd137,492$4.82M0.1%+1,714.1%0.121%
2/18/2026Ikarian Capital LLC45,830$1.61M0.1%-57.1%0.040%
2/18/2026Virtus Investment Advisers LLC7,142$251K0.1%+32.0%0.006%
2/18/2026Twinbeech Capital LP27,400$961K0.1%N/A0.024%
2/18/2026Millennium Management LLC254,596$8.93M0.0%N/A0.225%
2/18/2026Ishara Investments LP30,000$1.05M1.2%N/A0.026%
2/18/2026Janus Henderson Group PLC2,341,723$82.30M0.0%+10.6%2.065%
2/18/2026Eversept Partners LP420,827$14.76M0.7%-13.9%0.371%
2/18/2026Castle Hook Partners LP1,085,008$38.06M0.2%N/A0.957%
2/18/2026Cormorant Asset Management LP1,000,000$35.08M1.6%-54.0%0.882%
2/18/2026Artia Global Partners LP503,936$17.68M2.4%+158.6%0.444%
2/18/2026Boothbay Fund Management LLC33,919$1.19M0.0%-16.7%0.030%
2/17/2026Guggenheim Capital LLC6,388$224K0.0%N/A0.006%
2/17/2026Logos Global Management LP450,000$15.79M1.0%N/A0.397%
2/17/2026Viking Global Investors LP4,203,567$147.46M0.4%-35.1%3.707%
2/17/2026ADAR1 Capital Management LLC118,623$4.16M0.3%+3.7%0.105%
2/17/2026Jain Global LLC47,584$1.67M0.0%N/A0.042%
2/17/2026RA Capital Management L.P.9,550,191$335.02M3.4%-5.8%8.422%
2/17/2026Bain Capital Life Sciences Investors LLC7,306,566$256.31M19.6%-31.8%6.444%
2/17/2026ArrowMark Colorado Holdings LLC298,077$10.46M0.2%-4.2%0.263%
One coin wired into Elon's vision (Ad)

For the first time in history, the Federal Reserve is being led by someone who actually believes in crypto. Kevin Warsh has called Bitcoin "the new gold." He's invested personally in blockchain projects. He's gone on record saying digital assets are "part of the fabric of our financial services." This isn't a Fed Chair who tolerates crypto. This is one who understands it.tc pixel

See our #1 crypto pick for the new Fed era.
2/17/2026Price T Rowe Associates Inc. MD116,258$4.08M0.0%-16.0%0.103%
2/17/2026Adage Capital Partners GP L.L.C.1,406,631$49.35M0.1%-45.4%1.241%
2/17/2026California State Teachers Retirement System40,276$1.41M0.0%-15.8%0.036%
2/17/2026 Russell Investments Group Ltd.71,282$2.50M0.0%N/A0.063%
2/17/2026Fcpm Iii Services B.V.9,198,900$322.70M42.8%-0.1%8.113%
2/17/2026State of Wisconsin Investment Board19,997$701K0.0%N/A0.018%
2/17/2026Fred Alger Management LLC47,535$1.67M0.0%+15.2%0.042%
2/17/2026Royal Bank of Canada24,084$846K0.0%-9.1%0.021%
2/17/2026 Persistent Asset Partners Ltd3,948$138K0.1%N/A0.003%
2/17/2026Polar Capital Holdings Plc2,776,222$97.39M0.4%-4.7%2.448%
2/16/2026Squarepoint Ops LLC30,819$1.08M0.0%+47.0%0.027%
2/16/2026Verition Fund Management LLC32,391$1.14M0.0%+134.2%0.029%
2/16/2026PEAK6 LLC20,749$728K0.0%N/A0.018%
2/16/2026Nicholas Investment Partners LP213,419$7.49M0.5%+20.2%0.188%
2/16/2026First Turn Management LLC893,473$31.34M3.6%+24.6%0.788%
2/16/2026Frazier Life Sciences Management L.P.16,943,774$594.39M16.0%+1.4%14.943%
2/16/2026Kennedy Capital Management LLC172,931$6.07M0.1%+17.9%0.153%
2/13/2026Maverick Capital Ltd.1,894,226$66.45M0.7%+25.9%1.671%
2/13/2026 Walleye Capital LLC96,261$3.38M0.0%N/A0.085%
2/13/2026Quarry LP3,000$105K0.0%-56.4%0.003%
2/13/2026First Trust Advisors LP279,701$9.81M0.0%N/A0.247%
2/13/2026State Street Corp68,523$2.40M0.0%+7.4%0.060%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC265,199$9.30M0.0%N/A0.234%
2/13/2026 Wells Fargo & Company MN900$32K0.0%+50.0%0.001%
2/13/2026Lord Abbett & CO. LLC200,638$7.04M0.0%N/A0.177%
2/12/2026Orion Porfolio Solutions LLC6,545$230K0.0%N/A0.006%
2/12/2026Decheng Capital LLC592,057$20.77M2.8%-9.9%0.522%
2/12/2026Ensign Peak Advisors Inc549,511$19.28M0.0%N/A0.485%
2/12/2026 AlphaCentric Advisors LLC13,731$482K0.5%N/A0.012%
2/12/2026CIBC Private Wealth Group LLC7,240$254K0.0%-5.2%0.006%
2/12/2026 Alps Advisors Inc.92,902$3.26M0.0%N/A0.082%
2/12/2026 Swiss National Bank88,900$3.12M0.0%+2.1%0.078%
2/12/2026Polen Capital Management LLC11,239$394K0.0%N/A0.010%
2/11/2026Empowered Funds LLC2,428$85K0.0%N/A0.002%
2/11/2026 DCF Advisers LLC160,600$5.63M1.5%-8.4%0.142%
2/11/2026 Deutsche Bank AG123,963$4.35M0.0%+81.2%0.109%
2/11/2026 Fox Run Management L.L.C.9,798$344K0.1%N/A0.009%
2/11/2026Franklin Resources Inc.769,120$26.98M0.0%+89.5%0.678%
2/11/2026 CenterBook Partners LP12,060$423K0.0%-82.9%0.011%
2/11/2026JPMorgan Chase & Co.999,976$35.08M0.0%-23.2%0.882%
2/11/2026Capital World Investors9,984,000$350.24M0.0%+1.6%8.805%
2/11/2026 WINTON GROUP Ltd28,665$1.01M0.0%N/A0.025%
2/10/2026 TD Asset Management Inc13,180$462K0.0%-26.8%0.012%
2/10/2026Goldman Sachs Group Inc.1,725,662$60.54M0.0%+96.0%1.522%
2/10/2026JTC Employer Solutions Trustee Ltd75,500$2.65M0.2%N/A0.067%
2/10/2026 SBI Okasan Asset Management Co.Ltd.14,900$522K0.0%N/A0.013%
2/9/2026Geode Capital Management LLC102,395$3.59M0.0%+0.4%0.090%
2/9/2026 Knights of Columbus Asset Advisors LLC32,483$1.14M0.1%-3.4%0.029%
2/9/2026 Swedbank AB90,900$3.19M0.0%N/A0.080%
2/9/2026 Lisanti Capital Growth LLC179,410$6.29M1.5%+278.1%0.158%
One coin wired into Elon's vision (Ad)

The Kevin Warsh Fed takeover is here. And he's brought a thesis with him that almost nobody is talking about. Warsh believes AI is deflationary. That productivity gains from artificial intelligence are quietly crushing inflation in the background… which gives the Fed cover to cut rates even while the economy is strong. If we're right, the macro environment flips bullish fast. And this asset sits at the intersection of two of the most powerful forces in the market right now.tc pixel

2/6/2026Legato Capital Management LLC83,833$2.94M0.3%+258.7%0.074%
2/6/2026Mizuho Markets Cayman LP47,879$1.68M0.1%N/A0.042%
2/6/2026 PSP Research LLC14,920$523K0.5%N/A0.013%
2/6/2026 Atle Fund Management AB197,036$6.91M2.2%+1.8%0.174%
2/6/2026 Handelsbanken Fonder AB415,800$14.59M0.0%+2.5%0.367%
2/6/2026 TimesSquare Capital Management LLC822,300$28.85M0.4%-1.8%0.725%
2/5/2026DNB Asset Management AS20,119$706K0.0%N/A0.018%
2/5/2026 Navalign LLC1,315$46K0.0%N/A0.001%
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al7,200$253K0.0%N/A0.006%
2/3/2026 Swedbank AB90,900$3.19M0.0%N/A0.080%


NAMS Institutional Ownership - Frequently Asked Questions

During the previous two years, 190 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($594.39M), Capital World Investors ($350.24M), RA Capital Management L.P. ($335.02M), Fcpm Iii Services B.V. ($322.70M), Bain Capital Life Sciences Investors LLC ($256.31M), Viking Global Investors LP ($147.46M), and Deerfield Management Company L.P. ($121.35M).Learn more on NewAmsterdam Pharma's institutional investors.

89.89% of NewAmsterdam Pharma's stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings.

Of the 168 institutional investors that purchased NewAmsterdam Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($6.38M), Frazier Life Sciences Management L.P. ($4.62M), Jennison Associates LLC ($4.31M), Deerfield Management Company L.P. Series C ($3.61M), Capital World Investors ($2.61M), Alliancebernstein L.P. ($2.33M), and RA Capital Management L.P. ($2.07M).

Institutional investors have bought a total of 21,984,105 shares in the last 24 months. This purchase volume represents approximately $599.94M in transactions.

Of the 54 institutional investors that sold NewAmsterdam Pharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($3.41M), Viking Global Investors LP ($2.77M), Jennison Associates LLC ($2.47M), Fcpm Iii Services B.V. ($1.43M), Pictet Asset Management Holding SA ($1.29M), Cormorant Asset Management LP ($1.18M), and Adage Capital Partners GP L.L.C. ($1.17M).

Institutional investors have sold a total of 19,128,956 shares in the last 24 months. This volume of shares sold represents approximately $605.52M in transactions.



This page (NASDAQ:NAMS) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners